Patents by Inventor Shrinivas Purandare

Shrinivas Purandare has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10420727
    Abstract: A pharmaceutical composition comprises at least one integrase inhibitor or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug and at least one antiretroviral or anti-HIV agent or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: September 24, 2019
    Assignee: Cipla Limited
    Inventors: Geena Malhotra, Shrinivas Purandare
  • Publication number: 20180250271
    Abstract: A pharmaceutical composition comprises at least one integrase inhibitor or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug and at least one antiretroviral or anti-HIV agent or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug.
    Type: Application
    Filed: May 7, 2018
    Publication date: September 6, 2018
    Inventors: Geena MALHOTRA, Shrinivas PURANDARE
  • Patent number: 10004721
    Abstract: A pharmaceutical composition comprises at least one integrase inhibitor or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug and at least one antiretroviral or anti-HIV agent or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug.
    Type: Grant
    Filed: October 23, 2013
    Date of Patent: June 26, 2018
    Assignee: Cipla Limited
    Inventors: Geena Malhotra, Shrinivas Purandare
  • Patent number: 9402854
    Abstract: The present invention relates to a pharmaceutical composition comprising arformoterol and fluticasone furoate (preferably for once daily administration), to a process for preparing such a composition and to the use of such a composition for the treatment and/or prevention of respiratory, inflammatory or obstructive airway disease.
    Type: Grant
    Filed: April 10, 2013
    Date of Patent: August 2, 2016
    Assignee: Cipla Limited
    Inventors: Shrinivas Purandare, Geena Madhukar Malhotra
  • Publication number: 20150250713
    Abstract: The present invention relates to a pharmaceutical composition comprising tiotropium, a hydrofluoroalkane (HFA) propellant, and optionally one or more pharmaceutically acceptable excipients; to a process for preparing such a pharmaceutical composition, and the use thereof in medicine, in particular for the prophylaxis and treatment of respiratory disorders.
    Type: Application
    Filed: October 23, 2013
    Publication date: September 10, 2015
    Applicant: CIPLA Limited
    Inventors: Geena Malhotra, Shrinivas Purandare
  • Publication number: 20150231079
    Abstract: A pharmaceutical composition comprises at least one integrase inhibitor or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug and at least one antiretroviral or anti-HIV agent or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug.
    Type: Application
    Filed: October 23, 2013
    Publication date: August 20, 2015
    Inventors: Geena Malhotra, Shrinivas Purandare
  • Publication number: 20150133472
    Abstract: The present invention relates to a pharmaceutical composition comprising voriconazole and an aqueous, non-aqueous, or oily vehicle, or a mixture thereof, and optionally one or more pharmaceutically acceptable excipients; to a process for preparing such a composition, and to the use of such a composition for the prevention or treatment of fungal infections.
    Type: Application
    Filed: May 10, 2013
    Publication date: May 14, 2015
    Inventors: Shrinivas Purandare, Geena Malhotra
  • Publication number: 20150080358
    Abstract: The present invention relates to a pharmaceutical composition comprising arformoterol and fluticasone furoate (preferably for once daily administration), to a process for preparing such a composition and to the use of such a composition for the treatment and/or prevention of respiratory, inflammatory or obstructive airway disease.
    Type: Application
    Filed: April 10, 2013
    Publication date: March 19, 2015
    Inventors: Shrinivas Purandare, Geena Madhukar Malhotra